Article
Atlanta-CIBA Vision will purchase the posterior-chamber phakic refractive lens (PRL) from Medennium.
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
FDA clears path for US IDE study of Myra Vision’s titratable glaucoma therapy
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
AI applications in cataract surgery: A surgeon’s perspective
(EyePod) From idea to impact: Navigating ophthalmic innovation
First FDA-approved treatment for MacTel performed
Wills Eye Hospital names Julia A. Haller, MD, as new chief executive officer